Excelsior Correspondent
SRINAGAR, Dec 11: Novo Nordisk India Private Limited and Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Soura have signed a landmark Memorandum of Understanding (MoU) to embark on a strategic collaboration focused on advancing clinical trials in India.
This partnership marks a significant milestone for both organizations as they join forces to innovate and transform the clinical research landscape, ultimately aiming to improve patient outcomes. Key dignitaries including Dr Mohammed Ashraf Ganie (Director, SKIMS); Dr Shariq Massodi- Dean, Medical Faculty, SKIMS and Dr Muzaffer Wani – Professor of Nephrology, SKIMS emphasized the collaborative potential of this initiative.
Commenting on the MoU signing, Vikrant Shrotriya, Managing Director and Corporate vice president, Novo Nordisk India Private Limited, said, “This partnership underscores our unwavering commitment to redefining the future of clinical research in India. By uniting our global expertise in innovative therapeutics with SKIMS’ exceptional medical infrastructure, we aim to create transformative healthcare solutions.”
Dr Mohammed Ashraf Ganie – Director-SKIMS said, “This collaboration represents a significant step towards elevating clinical research standards in the region. By collaborating with Novo Nordisk India Private Limited, SKIMS aims to contribute to groundbreaking advancements in medical science while ensuring that the people of Jammu and Kashmir have access to world-class healthcare.”
A first of its kind, this MoU for clinical trials with a medical institute in the region, is valid for three years and opens doors to long-term collaboration. The partnership aims to explore groundbreaking solutions in cardiology, obesity, nephrology and rare diseases by leveraging Novo Nordisk’s expertise in developing advanced therapeutics and SKIMS’ robust medical infrastructure.
As part of the MoU, Novo Nordisk will contribute to building research capacity by providing resources, clinical research, relevant trainings and project-related equipment. This initiative also aims to enhance the capabilities of the clinical research team at SKIMS, ensuring the outreach of life-saving medicines to larger patient population.
Follow our WhatsApp channel
